IRulya Therapeutics Cash Flow Statement
NASDAQ: IRLAHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
39.88-0.06 (-0.15%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
IRulya Therapeutics free cash flow
In fiscal 2025, IRulya Therapeutics generated -$41.4 million of operating cash flow and spent $352,000 on capital expenditures. That left free cash flow of -$41.8 million.
Summary generated from market data by MetaCap's automated system. Methodology
IRulya Therapeutics cash flow statement (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 | FY 20192019-12-31 | FY 20182018-12-31 |
|---|---|---|---|---|---|---|---|---|
| Net Income | -83.98M | -56.83M | -31.39M | -51.66M | -89.94M | -76.85M | -36.98M | -12.48M |
| Net Income growth (YoY) | — | — | — | — | — | — | — | — |
| Depreciation & Amortization | 142.00K | 186.00K | 322.00K | 204.00K | 344.00K | 332.00K | 188.00K | 51.00K |
| Stock-Based Compensation | 5.11M | 4.75M | 5.22M | 16.62M | 29.85M | 14.47M | 2.06M | 155.00K |
| Change in Working Capital | 2.76M | -675.00K | 3.96M | -3.36M | 527.00K | 2.66M | -2.74M | -713.00K |
| Operating Cash Flow | -41.42M | -31.90M | -18.29M | -44.04M | -62.93M | -50.82M | -33.28M | -11.70M |
| Capital Expenditures | -352.00K | -257.00K | -160.00K | -133.00K | -180.00K | -52.00K | -55.00K | -212.00K |
| Investing Cash Flow | 23.23M | 21.91M | -5.76M | 18.00M | 58.95M | -52.43M | -17.75M | -46.75M |
| Financing Cash Flow | 17.91M | -4.78M | 143.00K | 707.00K | 6.81M | 118.88M | 77.37M | 75.93M |
| Net Change in Cash | -403.00K | -14.54M | -23.83M | -25.14M | 2.88M | 15.63M | 26.34M | 17.48M |
| Free Cash Flow | -41.78M | -32.16M | -18.45M | -44.17M | -63.11M | -50.87M | -33.33M | -11.91M |
This table shows 8 annual periods of IRulya Therapeutics's cash flow statement, from FY 2025 back to FY 2018, across 10 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow IRLA's reporting calendar. What is a cash flow statement?